A US Centers for Disease Control and Prevention (CDC)-led study identifies three clusters of post-COVID multisystem ...

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

The CROSS score accurately predicts the risk of ICU admission for patients with COVID-19 presenting at the emergency room.

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

Researchers have long known that patients who leave emergency departments before medically advised use more emergency care services, are more likely to be readmitted to the hospital and face higher ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Recognized experts in acute pulmonary care discuss the benefits of pulmonary rehabilitation for patients recovering from CAP, including COVID pneumonia. Air Supply: Targeting Eosinophils in Severe ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

SANTHI KUMAR PULMONOLOGY Associate Professor of Clinical Medicine, Pulmonary / Critical Care; Interim Chief, Division of Pulmonary, Critical Care and ...

Although hospitalizations from COVID are not as high ... The restrictions apply to patients and birthing mothers in pediatric inpatient units, pediatric ICU, neonatal ICU and birthing and ...